Amplified Photoacoustic Signal and Enhanced Photothermal Conversion of Polydopamine-Coated Gold Nanobipyramids for Phototheranostics and Synergistic Chemotherapy
- PMID: 32153178
- DOI: 10.1021/acsami.9b22979
Amplified Photoacoustic Signal and Enhanced Photothermal Conversion of Polydopamine-Coated Gold Nanobipyramids for Phototheranostics and Synergistic Chemotherapy
Abstract
Light-responsive nanoprobes were suffering from the threat of high-dose laser irradiation, and it was important for constructing new nanoprobes for safe and efficient phototheranostics. Here, polydopamine (PDA)-coated gold nanobipyramids (AuNBPs@PDA) were synthesized for amplified photoacoustic (PA) signal and enhanced photothermal conversion with low-dose laser irradiation and then doxorubicin (DOX)-loaded AuNBPs@PDA-DOX nanoprobes were constructed for PA imaging-guided synergistic photothermal therapy (PTT) and chemotherapy. The AuNBPs@PDA nanoparticles possessed higher photothermal conversion efficiency (42.07%) and stronger PA signal than those of AuNBP nanoparticles, and the AuNBPs@PDA-DOX nanoprobes showed dual-responsive DOX release of pH and photothermal stimulation. With low-dose laser irradiation (1.0 W/cm2) and low-concentration AuNBPs@PDA-DOX (60 μg/mL), the 4T1 cell viability was reduced to about 5%, owing to the combination of PTT and chemotherapy, compared with 42.3% of single chemotherapy and 25.3% of single PTT. Moreover, by modeling 4T1 tumor-bearing nude mice, in vivo PA imaging was achieved and the tumors were completely inhibited, demonstrating the excellent synergistic effect of PTT/chemotherapy. Therefore, the developed AuNBPs@PDA-DOX nanoprobes can be used for phototheranostics and synergistic chemotherapy, achieving low-dose laser irradiation and high-efficient visualized theranostics.
Keywords: gold nanobipyramids; photoacoustic imaging; photothermal therapy; polydopamine; synergistic chemotherapy.
Similar articles
-
Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.Acta Biomater. 2017 Jan 1;47:124-134. doi: 10.1016/j.actbio.2016.10.010. Epub 2016 Oct 6. Acta Biomater. 2017. PMID: 27721008
-
Gold Nanorods-Based Smart Nanoplatforms for Synergic Thermotherapy and Chemotherapy of Tumor Metastasis.ACS Appl Mater Interfaces. 2019 Feb 27;11(8):7800-7811. doi: 10.1021/acsami.8b21784. Epub 2019 Feb 15. ACS Appl Mater Interfaces. 2019. PMID: 30720270
-
Combined Chemo- and Photothermal Therapies of Non-Small Cell Lung Cancer Using Polydopamine/Au Hollow Nanospheres Loaded with Doxorubicin.Int J Nanomedicine. 2024 Sep 14;19:9597-9612. doi: 10.2147/IJN.S473137. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39296938 Free PMC article.
-
Polydopamine-Based Nanoparticles for Photothermal Therapy/Chemotherapy and their Synergistic Therapy with Autophagy Inhibitor to Promote Antitumor Treatment.Chem Rec. 2021 Apr;21(4):781-796. doi: 10.1002/tcr.202000170. Epub 2021 Feb 26. Chem Rec. 2021. PMID: 33634962 Review.
-
Polydopamine-Incorporated Nanoformulations for Biomedical Applications.Macromol Biosci. 2020 Dec;20(12):e2000228. doi: 10.1002/mabi.202000228. Epub 2020 Aug 23. Macromol Biosci. 2020. PMID: 32830435 Review.
Cited by
-
Frontiers in Preparations and Promising Applications of Mesoporous Polydopamine for Cancer Diagnosis and Treatment.Pharmaceutics. 2022 Dec 21;15(1):15. doi: 10.3390/pharmaceutics15010015. Pharmaceutics. 2022. PMID: 36678644 Free PMC article. Review.
-
Polydopamine-coated i-motif DNA/Gold nanoplatforms for synergistic photothermal-chemotherapy.Asian J Pharm Sci. 2023 Mar;18(2):100781. doi: 10.1016/j.ajps.2023.100781. Epub 2023 Feb 1. Asian J Pharm Sci. 2023. PMID: 36818397 Free PMC article.
-
Recent Advances in a Polydopamine-Mediated Antimicrobial Adhesion System.Front Microbiol. 2021 Jan 12;11:607099. doi: 10.3389/fmicb.2020.607099. eCollection 2020. Front Microbiol. 2021. PMID: 33510726 Free PMC article. Review.
-
Curcumin-enhanced NIR-II-responsive gold nanobipyramids for targeted HSP 90 inhibition.Mater Today Bio. 2025 Feb 1;31:101541. doi: 10.1016/j.mtbio.2025.101541. eCollection 2025 Apr. Mater Today Bio. 2025. PMID: 39990737 Free PMC article.
-
Effect of reducing agents on the synthesis of anisotropic gold nanoparticles.Nano Converg. 2022 Jan 17;9(1):5. doi: 10.1186/s40580-021-00296-1. Nano Converg. 2022. PMID: 35038061 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical